• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | Inspections
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameDEXCOM CGM
Classification Namesensor, glucose, invasive
ApplicantDEXCOM, INC.
PMA NumberP050012
Supplement NumberS045
Date Received02/21/2012
Decision Date08/17/2012
Product Code
MDS[ Registered Establishments with MDS ]
Advisory Committee Clinical Chemistry
Supplement Typenormal 180 day track
Supplement Reason change design/components/specifications - component
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for 1) the addition of new components to the global transmitter/global receiver system allowing communication at 2. 4 ghz; 2) minor modifications to the applicator bail and safety card; and 3) updates to the optional data manager software that is provided with the seven plus cgm system. The device, as modified, will be marketed under the trade name dexcom color continuous glucose monitoring (cgm) system, and is a glucose-monitoring device indicated for detecting and tracking glucose trends and patterns to aid in the detection of episodes of hyperglycemia and hypoglycemia in adults with diabetes. The system is intended for single patient use and requires a prescription.
-
-